Literature DB >> 18376001

Cholesterol lowering and ezetimibe.

Jeffrey M Drazen, John A Jarcho, Stephen Morrissey, Gregory D Curfman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18376001     DOI： 10.1056/NEJMe0801842

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Late-breaking trials at the ACC scientific sessions: insights and controversy.

Authors:  Steven E Nissen
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

2.  Evaluation of Fibrous Cap Rupture of Atherosclerotic Carotid Plaque with Thin-Slice Source Images of Time-of-Flight MR Angiography.

Authors:  Yuji Watanabe; Masako Nagayama; Akihiko Sakata; Akira Okumura; Yoshiki Amoh; Takayoshi Ishimori; Satoru Nakashita; Yoshihiro Dodo
Journal:  Ann Vasc Dis       Date:  2014-05-16

Review 3.  MR plaque imaging of the carotid artery.

Authors:  Yuji Watanabe; Masako Nagayama
Journal:  Neuroradiology       Date:  2010-02-13       Impact factor: 2.804

Review 4.  Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.

Authors:  Richard Kones; Umme Rumana
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

Review 5.  Dyslipidemia in youth with diabetes: to treat or not to treat?

Authors:  David M Maahs; R Paul Wadwa; Franziska Bishop; Stephen R Daniels; Marian Rewers; Georgeanna J Klingensmith
Journal:  J Pediatr       Date:  2008-10       Impact factor: 4.406

6.  Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.

Authors:  Joseph S Ross; Sharon G Frazee; Susan B Garavaglia; Rebecca Levin; Haik Novshadian; Cynthia A Jackevicius; Glen Stettin; Harlan M Krumholz
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

Review 7.  Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia.

Authors:  Ian Hamilton-Craig; Karam Kostner; David Colquhoun; Stan Woodhouse
Journal:  Vasc Health Risk Manag       Date:  2010-11-10

8.  Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events.

Authors:  Venkatesh Mani; Paul Muntner; Samuel S Gidding; Silvia H Aguiar; Hamza El Aidi; Karen B Weinshelbaum; Hiroaki Taniguchi; Rob van der Geest; Johan H C Reiber; Sameer Bansilal; Michael Farkouh; Valentin Fuster; John E Postley; Mark Woodward; Zahi A Fayad
Journal:  J Cardiovasc Magn Reson       Date:  2009-04-24       Impact factor: 5.364

9.  Fact or fiction: the need for independent pharmaceutical policy research.

Authors:  Salomeh Keyhani; Alex Federman
Journal:  J Gen Intern Med       Date:  2009-05       Impact factor: 5.128

10.  Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia.

Authors:  Minako Yamaoka-Tojo; Taiki Tojo; Rie Kosugi; Yuko Hatakeyama; Yuki Yoshida; Yoji Machida; Naoyoshi Aoyama; Takashi Masuda; Tohru Izumi
Journal:  Lipids Health Dis       Date:  2009-10-12       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.